Cargando…

The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression

OBJECTIVE: The aim of this study was to analyze the percentages of T helper 17 cells (Th17s) and T regulatory cells (Tregs) in autoimmune Hashimoto’s thyroiditis (HT), and the expression of the checkpoint molecules programmed death receptor 1/programmed death ligand 1 (PD-1/PD-L1) on these cells. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Jun, Yu, Lei, Zhuang, Lan-Gen, Pei, Xiao-Yan, Wang, Qiong, Jin, Guo-Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454193/
https://www.ncbi.nlm.nih.gov/pubmed/36093111
http://dx.doi.org/10.3389/fendo.2022.959477
_version_ 1784785298371117056
author Fang, Jun
Yu, Lei
Zhuang, Lan-Gen
Pei, Xiao-Yan
Wang, Qiong
Jin, Guo-Xi
author_facet Fang, Jun
Yu, Lei
Zhuang, Lan-Gen
Pei, Xiao-Yan
Wang, Qiong
Jin, Guo-Xi
author_sort Fang, Jun
collection PubMed
description OBJECTIVE: The aim of this study was to analyze the percentages of T helper 17 cells (Th17s) and T regulatory cells (Tregs) in autoimmune Hashimoto’s thyroiditis (HT), and the expression of the checkpoint molecules programmed death receptor 1/programmed death ligand 1 (PD-1/PD-L1) on these cells. METHODS: This is a case-control study involving 53 initially diagnosed HT patients (HT group) and 21 normal controls (NC group). The peripheral blood mononuclear cells from the individuals of the two groups were isolated and restimulated ex vivo; the percentage of Th17s, Tregs, PD-1(+) Th17s, PD-L1(+) Th17s, PD-1(+) Tregs, and PD-L1(+) Tregs was assessed by flow cytometric analysis. RESULTS: (1) The percentage of Th17s in the peripheral blood of the HT group was significantly higher than that of the NC group [(6.38 ± 1.32)% versus (3.12 ± 0.66)%; t = 14.110, P < 0.001], while the percentage of peripheral blood Tregs was significantly lower [(3.82 ± 1.48)% versus (5.61 ± 1.60)%; t = −4.599, P < 0.001]. (2) HT patients’ Th17s expressed PD-1 at a significantly lower frequency than their counterparts in the NC [(6.46 ± 2.77)% versus (18.51 ± 3.96)%; t = −14.842, P < 0.001], while no difference was observed for PD-L1 between the two groups. (3) In contrast, both PD-1 and PD-L1 were expressed at significantly higher frequency on HT patients’ Tregs than on NC [respectively: (17.01 ± 3.04)% versus (10.23 ± 2.77)%; t = 8.850, P < 0.001 for PD-1; (16.60 ± 9.58)% versus (11.36 ± 10.14)%; t = 2.089, P < 0.005, for PD-L1]. CONCLUSION: (1) The increased percentage of Th17s and decreased percentage of PD-1(+) Th17s in the HT group suggest that a loss of control on Th17 activity through the checkpoint inhibitory axis PD-1/PD-L1 may participate in disease pathogenesis. (2) While the decreased percentage of Tregs in HT patients may explain a lack of regulatory functions able to prevent the autoimmune destruction of the thyroid, the significance of the increased frequency of Tregs expressing PD-1 and PD-L1, previously reported to boost Tregs differentiation, remains to be established. Elucidating this apparent contradiction may reveal important mechanisms underlying HT pathogenesis.
format Online
Article
Text
id pubmed-9454193
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94541932022-09-09 The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression Fang, Jun Yu, Lei Zhuang, Lan-Gen Pei, Xiao-Yan Wang, Qiong Jin, Guo-Xi Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: The aim of this study was to analyze the percentages of T helper 17 cells (Th17s) and T regulatory cells (Tregs) in autoimmune Hashimoto’s thyroiditis (HT), and the expression of the checkpoint molecules programmed death receptor 1/programmed death ligand 1 (PD-1/PD-L1) on these cells. METHODS: This is a case-control study involving 53 initially diagnosed HT patients (HT group) and 21 normal controls (NC group). The peripheral blood mononuclear cells from the individuals of the two groups were isolated and restimulated ex vivo; the percentage of Th17s, Tregs, PD-1(+) Th17s, PD-L1(+) Th17s, PD-1(+) Tregs, and PD-L1(+) Tregs was assessed by flow cytometric analysis. RESULTS: (1) The percentage of Th17s in the peripheral blood of the HT group was significantly higher than that of the NC group [(6.38 ± 1.32)% versus (3.12 ± 0.66)%; t = 14.110, P < 0.001], while the percentage of peripheral blood Tregs was significantly lower [(3.82 ± 1.48)% versus (5.61 ± 1.60)%; t = −4.599, P < 0.001]. (2) HT patients’ Th17s expressed PD-1 at a significantly lower frequency than their counterparts in the NC [(6.46 ± 2.77)% versus (18.51 ± 3.96)%; t = −14.842, P < 0.001], while no difference was observed for PD-L1 between the two groups. (3) In contrast, both PD-1 and PD-L1 were expressed at significantly higher frequency on HT patients’ Tregs than on NC [respectively: (17.01 ± 3.04)% versus (10.23 ± 2.77)%; t = 8.850, P < 0.001 for PD-1; (16.60 ± 9.58)% versus (11.36 ± 10.14)%; t = 2.089, P < 0.005, for PD-L1]. CONCLUSION: (1) The increased percentage of Th17s and decreased percentage of PD-1(+) Th17s in the HT group suggest that a loss of control on Th17 activity through the checkpoint inhibitory axis PD-1/PD-L1 may participate in disease pathogenesis. (2) While the decreased percentage of Tregs in HT patients may explain a lack of regulatory functions able to prevent the autoimmune destruction of the thyroid, the significance of the increased frequency of Tregs expressing PD-1 and PD-L1, previously reported to boost Tregs differentiation, remains to be established. Elucidating this apparent contradiction may reveal important mechanisms underlying HT pathogenesis. Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9454193/ /pubmed/36093111 http://dx.doi.org/10.3389/fendo.2022.959477 Text en Copyright © 2022 Fang, Yu, Zhuang, Pei, Wang and Jin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Fang, Jun
Yu, Lei
Zhuang, Lan-Gen
Pei, Xiao-Yan
Wang, Qiong
Jin, Guo-Xi
The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression
title The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression
title_full The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression
title_fullStr The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression
title_full_unstemmed The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression
title_short The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression
title_sort changes in peripheral blood th17 and treg ratios in hashimoto’s thyroiditis are accompanied by differential pd-1/pd-l1 expression
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454193/
https://www.ncbi.nlm.nih.gov/pubmed/36093111
http://dx.doi.org/10.3389/fendo.2022.959477
work_keys_str_mv AT fangjun thechangesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT yulei thechangesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT zhuanglangen thechangesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT peixiaoyan thechangesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT wangqiong thechangesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT jinguoxi thechangesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT fangjun changesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT yulei changesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT zhuanglangen changesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT peixiaoyan changesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT wangqiong changesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression
AT jinguoxi changesinperipheralbloodth17andtregratiosinhashimotosthyroiditisareaccompaniedbydifferentialpd1pdl1expression